Sandoz Group AG(SDZNY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SDZNY Sandoz Group AG

未开盘 05-07 16:00:00 EDT 延时

{"stockData":{"symbol":"SDZNY","market":"US","secType":"STK","nameCN":"Sandoz Group AG","latestPrice":44.36,"timestamp":1746648000000,"preClose":44.7,"halted":0,"volume":88575,"delay":15,"floatShares":399980000,"shares":431000000,"eps":-0.018602,"marketStatus":"未开盘","change":-0.34,"latestTime":"05-07 16:00:00 EDT 延时","open":46,"high":46,"low":44.32,"amount":3958320.185900004,"amplitude":0.037584,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.018602,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746691200000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"OTCQX","adjPreClose":44.7,"volumeRatio":4.289762},"requestUrl":"/m/hq/s/SDZNY","defaultTab":"news","newsList":[{"id":"2531605177","title":"复宏汉霖与山德士就伊匹木单抗生物类似药达成授权合作，总金额超3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531605177","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531605177?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:38","pubTimestamp":1745941080,"startTime":"0","endTime":"0","summary":"根据协议条款，复宏汉霖将负责HLX13的研发、生产以及商业化供应，并从交易中获得3.01亿美元的潜在收入，其中3100万美元为交易首付款。作为全球仿制药与生物类似药领域的领导者，山德士始终以\"让健康触手可及\"为使命，凭借约1,300款产品累计惠及全球9亿患者。此次复宏汉霖携手山德士，将充分借力其成熟的全球网络与生物类似药商业化优势，加速HLX13在全球主流生物药市场的可及性。此次与山德士的合作，将进一步提升公司产品的全球可及性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4675725_ZH75725_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","BK1161","02696","SDZNY"],"gpt_icon":0},{"id":"1111075095","title":"Sandoz集团公布2024财年净销售额为103.6亿美元，低于预期的104.1亿美元，每股收益为2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111075095","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111075095?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:01","pubTimestamp":1741161697,"startTime":"0","endTime":"0","summary":"Sandoz集团公布2024财年净销售额为103.6亿美元，低于预期的104.1亿美元，调整后每股收益为2.71美元。以上内容来自Benzinga Earnings专栏，原文如下：Sandoz Group AG Reported FY24 Net Sales Of $10.36B Vs $10.41B Est, Adj EPS Of $2.71","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDZNY","AG"],"gpt_icon":0},{"id":"1182104028","title":"减肥药市场要“变天”？诺和诺德与礼来的“平替”竞争对手出现了","url":"https://stock-news.laohu8.com/highlight/detail?id=1182104028","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182104028?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:40","pubTimestamp":1727257205,"startTime":"0","endTime":"0","summary":"梯瓦制药和Sandoz等已推出首批仿制药。","market":"us","thumbnail":"https://static.tigerbbs.com/37608d89603126004448a295afb49463","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/37608d89603126004448a295afb49463"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDZNY","NVO","TEVA","LLY"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.sandoz.com/","exchange":"OTCQX","name":"Sandoz Group AG","nameEN":"Sandoz Group AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sandoz Group AG(SDZNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sandoz Group AG(SDZNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sandoz Group AG,SDZNY,Sandoz Group AG股票,Sandoz Group AG股票老虎,Sandoz Group AG股票老虎国际,Sandoz Group AG行情,Sandoz Group AG股票行情,Sandoz Group AG股价,Sandoz Group AG股市,Sandoz Group AG股票价格,Sandoz Group AG股票交易,Sandoz Group AG股票购买,Sandoz Group AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sandoz Group AG(SDZNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sandoz Group AG(SDZNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}